Course Information
MMI/Pfizer Workshop - MOLECULES TO MEDICINES - How Biopharma Delivers
.jpg)
Date(s): 6 November 2009
Main Venue:
William Stokes Postgraduate Centre
St James's Hospital , James Street, Dublin 8
Location »
Online Application Period: Contact education@molecularmedicineireland.ie
Please note that in order to reflect that Wyeth is now part of Pfizer, the workshop title has been changed to MMI/Pfizer Workshop -Molecules to Medicines-How Biopharma Delivers
| Quicklink to items on this page: |
This MMI/Pfizer 1-day workshop, for 24 participants, comprises discussion of key issues arising during biopharmaceutical discovery, development, and manufacturing. It will include breakout group discussion of specially devised problem sets.
This workshop is open to postgraduate students with research experience (e.g. at least one year into their PhD studies). If you are interested in attending this workshop please send an email indicating your interest to education@MolecularMedicineIreland.ie after you have applied online for the lecture course. Attendance at the lecture course on the preceding day (Thu 6 Nov 2009) is compulsory - details are here. The workshop was oversubscribed when it ran last year, so you are advised to apply early.
Course/Workshop Developers:
Dr Davinder Gill (Assistant Vice President, Biologic Therapeutics, Pfizer Pharmaceuticals, Cambridge, MA, USA)
Dr Brendan Hughes (Director of Development, Pfizer Ireland, Grange Castle)
Dr Mark Leonard (Director, Gene Expression Technologies, Pfizer BioPharma Campus, Andover, MA, USA)
Comments from participants on last year's Workshop:''Good insight into the industry and the drug discovery process. Useful workshop and group discussions'' |
![]() |
WORKSHOP: Friday 6 November (0930-1800)
| 0930 | Introduction to the workshop: key issues in discovery, development, and manufacturing | |
| 1020 | Tea/Coffee | |
| DISCOVERY | ||
| 1040 | Issues in discovery: defining the breakout session problem set | |
| 1120 | Breakout session 1: issues in discovery | |
| 1200 | Breakout session 1 feedback | |
| 1240 | Lunch break (lunch will be provided) | |
| DEVELOPMENT | ||
| 1320 | Issues in development: defining the breakout session problem set | |
| 1400 | Breakout session 2: issues in development | |
| 1440 | Breakout session 2 feedback | |
| 1520 | Coffee/Tea | |
| MANUFACTURING | ||
| 1540 | Issues in manufacturing: defining the breakout session problem set | |
| 1620 | Breakout session 3: issues in manufacturing | |
| 1700 | Breakout session 3 feedback | |
| 1740 | Discussion: key learnings | |
| Please click here to print the schedule | ||
Workshop Instructors
Workshop Instructors comprise key personnel from Pfizer
Dr Paul Dillon (Senior Scientist, Pfizer Grange Castle)
Dr Jonny Finlay (Research scientist, Global Biologic Therapeutics, Pfizer Grange Castle)
Dr Patrick Gammell (Scientist, Pfizer Grange Castle)
Workshop Sponsor
